These results indicate that CD8+ cells included mostly GPC3 peptide-specific CTLs that had cytotoxic activity against cancer cells and endogenously presented GPC3 peptide, and CD8− cells included mostly γδ T cells that had cytotoxic activity against cancer cells. This evidence concerns the gene GPC3 and cancer.